Surgical Science Sweden AB (publ) (STO: SUS)
Sweden
· Delayed Price · Currency is SEK
175.00
-1.40 (-0.79%)
Jan 20, 2025, 5:29 PM CET
STO: SUS Revenue
Surgical Science Sweden AB had revenue of 231.83M SEK in the quarter ending September 30, 2024, with 10.27% growth. This brings the company's revenue in the last twelve months to 859.83M, down -5.06% year-over-year. In the year 2023, Surgical Science Sweden AB had annual revenue of 882.85M with 10.01% growth.
Revenue (ttm)
859.83M
Revenue Growth
-5.06%
P/S Ratio
10.39
Revenue / Employee
3.18M
Employees
260
Market Cap
8.93B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 882.85M | 80.31M | 10.01% |
Dec 31, 2022 | 802.54M | 435.76M | 118.81% |
Dec 31, 2021 | 366.78M | 261.98M | 249.98% |
Dec 31, 2020 | 104.80M | 3.28M | 3.23% |
Dec 31, 2019 | 101.52M | 35.82M | 54.51% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 25.44B |
Getinge AB | 33.59B |
Sectra AB | 3.14B |
Camurus AB | 1.69B |
Medicover AB | 22.60B |
Vitrolife AB | 3.56B |
Bonesupport Holding AB | 814.46M |
Elekta AB | 17.72B |